Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>

Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>

As antimicrobial resistance (AMR) continues to pose an ever-growing global health threat, propelling us into a post-antibiotic era, novel alternative therapeutic agents are urgently required. Lysins are bacteriophage-encoded peptidoglycan hydrolases that display great potential as a novel class of a...

Full description

Bibliographic Details
Main Authors:	Joash Jun Keat Chu, Wee Han Poh, Nabilah Taqiah Binte Hasnuddin, En Yi Hew, Linh Chi Dam, Abbas El Sahili, Scott A. Rice, Boon Chong Goh
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Antibiotics
Subjects:	phage lysin endolysin multidrug resistance <i>Acinetobacter baumannii</i> novel antibacterial agent
Online Access:	https://www.mdpi.com/2079-6382/11/2/169

Similar Items

Novel phage lysin Abp013 against Acinetobacter baumannii
by: Chu, Joash Jun Keat, et al.
Published: (2022)

Enhanced antibacterial activity of Acinetobacter baumannii bacteriophage ØABP-01 endolysin (LysABP-01) in combination with colistin
by: Rapee Thummeepak, et al.
Published: (2016-09-01)

Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant <em>Acinetobacter baumannii</em>
by: Yujing Tan, et al.
Published: (2022-12-01)

Characterization of a Novel Phage ΦAb1656-2 and Its Endolysin with Higher Antimicrobial Activity against Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Kyeongmin Kim, et al.
Published: (2021-09-01)

Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci
by: Hana Sakina Binte Muhammad Jai, et al.
Published: (2020-11-01)

Development of <i>Staphylococcus</i> Enzybiotics: The Ph28 Gene of <i>Staphylococcus epidermidis</i> Phage PH15 Is a Two-Domain Endolysin
by: Magdy Mohamed Muharram, et al.
Published: (2020-03-01)

Bacteriophage lysins as antibacterials
by: Umender Sharma, et al.
Published: (2017-05-01)

Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Acinetobacter baumannii
by: Md Maidul Islam, et al.
Published: (2022-09-01)

Wild-type Lactococcus lactis producing bacteriocin-like prophage lysins
by: Timo M. Takala, et al.
Published: (2023-07-01)

Gram-Negative Bacterial Lysins
by: Chandrabali Ghose, et al.
Published: (2020-02-01)

Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
by: Roberto Vázquez, et al.
Published: (2018-10-01)

Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant Acinetobacter baumannii: in vitro and in vivo study
by: Hayder Nsaif Jasim, et al.
Published: (2018-11-01)

Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii—An in silico approach
by: Abhishek Nandi, et al.
Published: (2022-11-01)

Antibacterial activity of a newly developed peptide-modified lysin against Acinetobacter baumannii and Pseudomonas aeruginosa
by: Hang eYang, et al.
Published: (2015-12-01)

Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
by: Vincent A. Fischetti
Published: (2018-06-01)

The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage
by: Behnam Sisakhtpour, et al.
Published: (2022-01-01)

Crystal Structures of Pyrophosphatase from <i>Acinetobacter baumannii</i>: Snapshots of Pyrophosphate Binding and Identification of a Phosphorylated Enzyme Intermediate
by: Yunlong Si, et al.
Published: (2019-09-01)

Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing <i>Clostridioides difficile</i> Infection
by: Khalid Alyahya, et al.
Published: (2023-06-01)

Antimicrobial peptide thanatin fused endolysin PA90 (Tha-PA90) for the control of Acinetobacter baumannii infection in mouse model
by: Jeonghyun Lim, et al.
Published: (2024-04-01)

A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
by: Fazal Mehmood Khan, et al.
Published: (2021-03-01)

Comprehensive Characterization of a <i>Streptococcus agalactiae</i> Phage Isolated from a Tilapia Farm in Selangor, Malaysia, and Its Potential for Phage Therapy
by: Megat Hamzah Megat Mazhar Khair, et al.
Published: (2023-05-01)

Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
by: Shukho Kim, et al.
Published: (2020-09-01)

L-lysine potentiates aminoglycosides against Acinetobacter baumannii via regulation of proton motive force and antibiotics uptake
by: Wanyan Deng, et al.
Published: (2020-01-01)

A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii
by: Minle Wu, et al.
Published: (2019-01-01)

Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products
by: Sheila M. Dreher-Lesnick, et al.
Published: (2015-12-01)

Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii
by: Minle Wu, et al.
Published: (2019-02-01)

Lysine Methyltransferase EhPKMT2 Is Involved in the In Vitro Virulence of <i>Entamoeba histolytica</i>
by: Susana Munguía-Robledo, et al.
Published: (2023-03-01)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020-04-01)

New Phage-Derived Antibacterial Enzyme PolaR Targeting <i>Rothia</i> spp.
by: Paulina Miernikiewicz, et al.
Published: (2023-08-01)

A New Phage Lysin Isolated from the Oral Microbiome Targeting <i>Streptococcus pneumoniae</i>
by: Imme van der Kamp, et al.
Published: (2020-12-01)

Recent Progress in Phage Therapy to Modulate Multidrug-Resistant <i>Acinetobacter baumannii</i>, including in Human and Poultry
by: Yan Zhang, et al.
Published: (2022-10-01)

Two Distinct Modes of Lysis Regulation in <i>Campylobacter Fletchervirus</i> and <i>Firehammervirus</i> Phages
by: Athina Zampara, et al.
Published: (2020-10-01)

Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application
by: Katarzyna M. Danis-Wlodarczyk, et al.
Published: (2021-12-01)

Bactericidal Activity of a Self-Biodegradable Lysine-Containing Dendrimer against Clinical Isolates of <i>Acinetobacter</i> Genus
by: Silvana Alfei, et al.
Published: (2021-07-01)

The Specific Capsule Depolymerase of Phage PMK34 Sensitizes <i>Acinetobacter baumannii</i> to Serum Killing
by: Karim Abdelkader, et al.
Published: (2022-05-01)

Isolation and Characterization of a Novel <i>Siphoviridae</i> Phage, vB_AbaS_TCUP2199, Infecting Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Meity Mardiana, et al.
Published: (2022-06-01)

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022-09-01)

Distinct mode of action of a highly stable, engineered phage lysin killing Gram-negative bacteria
by: Hans Gerstmans, et al.
Published: (2023-12-01)

Protein Aggregation is Associated with <i>Acinetobacter baumannii</i> Desiccation Tolerance
by: Xun Wang, et al.
Published: (2020-02-01)

Inhibition of <i>Listeria monocytogenes</i> by Phage Lytic Enzymes Displayed on Tailored Bionanoparticles
by: Edel Stone, et al.
Published: (2022-03-01)